Corrigendum: Vedolizumab in paediatric inflammatory Bowel Disease: A retrospective multi-centre experience from the paediatric IBD Porto Group of ESPGHAN
Publication date
2018-04-27
Authors
Ledder, Oren
Assa, Amit
Levine, Arie
Escher, Johanna C.
de Ridder, Lissy
Ruemmele, Frank
Shah, Neil
Shaoul, Ron
Wolters, VM
Rodrigues, Astor
Editors
Advisors
Supervisors
Document Type
Comment
Metadata
Show full item recordCollections
License
taverne
Abstract
In the original article, author Carsten Posovszky's surname was incorrectly spelt. This has now been corrected.
Keywords
Taverne, Gastroenterology
Citation
Ledder, O, Assa, A, Levine, A, Escher, J C, de Ridder, L, Ruemmele, F, Shah, N, Shaoul, R, Wolters, V M, Rodrigues, A, Uhlig, H H, Posovszky, C, Kolho, K L, Jakobsen, C, Cohen, S, Shouval, D S, de Meij, T, Martin-de-Carpi, J, Richmond, L, Bronsky, J, Friedman, M & Turner, D 2018, 'Corrigendum : Vedolizumab in paediatric inflammatory Bowel Disease: A retrospective multi-centre experience from the paediatric IBD Porto Group of ESPGHAN', Journal of Crohn's and Colitis, vol. 12, no. 5, pp. 630. https://doi.org/10.1093/ecco-jcc/jjx172